XIDE, RAYS, PLUG, XXII & Extended Watchlist

Exide Technologies XIDE
Our bottom bounce call of XIDE yesterday morning came just in the nick of time, as the stock opened at .1451, and saw a low of .13, before going on to hit a high of .2147, and ending the day at .195. All in all, a good play that afforded us a chance at intraday gains of up to
65%

It is important to remember that this is not a long-term play. The company has filed for Chapter 11, and its future is uncertain at best. No, we were in this one for a quick dead-cat bounce, and that’s just what we got.


Raystream Inc. RAYS
RAYS also made a nice intraday run yesterday, from its low of .0035, to a high of .0057 we were looking at possible gains of 63% That’s in addition to the 200%+ in gains that we’ve already seen from RAYS within the past few trading sessions.


Plug Power, Inc. PLUG
PLUG came off of the extended watchlist yesterday to rack in some modest yet respectable profits, gaining 24% on the day. We’ve been pounding the table on PLUG since February 15th, and since that time we’ve seen a low of .1155. To yesterday’s all-time high of .475, represents a 311% move.


22nd Century Group, Inc. XXII
Another play from yesterday’s extended watchlist that fared pretty well was XXII. It made a nice 19% intraday spike on more than 5X its 3mo. average volume before closing the day flat.


Extended Watchlist:
FORC, KNDI, BEAT, DOLE, LRAD, FNMA

BMSN, AMBS, AAPL & Extended Watchlist

BMSN has been like a rocket lately, blasting off since we first alerted the stock back on December 26th.We have seen five consecutive days of gains, with Monday’s action breaking a previous resistance point of .0021 and reaching a high of ,0024, before closing at .0016.Considering the momentum we witnessed over the past five sessions, we are expecting to see a pullback at some point. In such an event, we’d like to see the support hold off of the 50DMA of .001.

Our next key level of resistance is going to be at .0024. If it can get past that, the next level is .003, and .004 (200DMA).

___

 

Amarantus Bioscience, Inc. AMBS

We first began talking about AMBS on November 6th. Another one on a serious uptrend; in the past 14 days of trading, the stock has seen just two days of closing in the red.

AMBS will be co-hosting an international symposium , the #C4CT Concussion Awareness Conference, “with the purpose of bringing thought leaders in the field of Traumatic Brain Injury (“TBI”) drug and diagnostic research & development, professional athletes, former professional athletes and celebrity sports figureheads that share the Company’s, TCMG’s and Brewer’s desire to support research into new TBI treatments, sports leagues who have social and fiduciary responsibilities to improve player safety and caring for former players previously affected by TBI and cognitive disorders, as well as other key stakeholders in the ongoing social discussion regarding head injuries and their side effects.”

BARCHART.COM currently has AMBS rated a “100% Buy”

We had stated before that we were looking for a break past .13, and that it would bring us into bluesky breakout mode, and now that it has done so, we’re going to hold onto our hats, because there’s no telling where it could stop. We’d like to see .13 hold as the new base level of support.

___

Apple, Inc. AAPL

AAPL was as low as 510.24 on Dec. 21st, and dipping as low as 504.66 on December 27th. With all of the hype coming from “fiscal cliff” negotiations, Monday’s big rally (closed at 532.1729) has the stock trading close to 550.00 premarket today.

___
Extended Watchlist:

 MSSD, BTHR, FORC, PPHM, MDIN, CTIX, SNTL, DNYS, KWK, NOK